Salix Pharmaceuticals, Ltd. Launches National Colorectal Screening Education Campaign with Walgreens and the Colon Cancer Alliance
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) is partnering with Walgreens (NYSE, NASDAQ: WAG) and the Colon Cancer Alliance (CCA) to raise awareness and increase screenings for colorectal cancer. Together these organizations are launching a major health education campaign during the month of March. In addition to providing informational brochures aimed at early detection and prevention of colorectal cancer at over 5,600 Walgreens locations across the nation and online, the program provides continuing education for Walgreens' more than 20,000 pharmacists to become a resource for consumers who have questions about screening. Pharmacy staff will also receive pocket-sized guidelines for colonoscopy procedures endorsed by the major patient advocacy and professional organizations for quick and easy reference. Rounding out the campaign is a toll free helpline manned by Colon Cancer Alliance staff available to answer questions and offer further information. Although screening for colorectal cancer often leads to early detection and saves lives, national statistics suggest that fewer than 50 percent of those who are eligible go for screenings.